1,227 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B Sell
Article Searches
Wall Street Breakfast: Equities Face Worst Week Of 2017 https://seekingalpha.com/article/4097888-wall-street-breakfast-equities-face-worst-week-2017?source=feed_all_articles Aug 11, 2017 - World stocks are falling for a fourth day after President Trump doubled down on his North Korean rhetoric, stating his fire and fury statement wasn't tough enough. He also warned that if Kim Jong-un'
This former marketing exec is disrupting McKinsey and PwC with 'the Uber of consultancies' http://feeds.bizjournals.com/~r/industry_6/~3/2irHqokZgOs/this-former-marketing-exec-is-disrupting-mckinsey.html Jun 08, 2017 - The Gig Economy encapsulates a wide variety of workers. On one end, there's Airbnb and Uber. If you're someone trying to make extra money, startups of a certain ilk can be lucrative. But there's a higher end, too. They could be a seasoned manager or former consultant who ditched the large corporation and went into business for themselves. Gregg Fisher, a former marketing executive, noticed this trend and founded The Stem, a staffing network consisting of hundreds of experts looking to lend the…
Allergan CEO sees more millennials and men turning to aesthetic medical treatments https://www.cnbc.com/2017/08/07/allergan-ceo-more-millennials-men-turning-to-aesthetic-treatments.html Aug 07, 2017 - Jim Cramer sat down with Allergan CEO Brent Saunders to hear how millennials are turning to aesthetic enhancements.
The Opioid Abuse Epidemic: What's The Investment Angle? https://seekingalpha.com/article/4084042-opioid-abuse-epidemic-investment-angle?source=feed_tag_editors_picks Jun 26, 2017 - The opioid abuse epidemic is destroying American lives, families and the fabric of American communities. The action taken to address the crisis by socio-political-legal means has placed both pain pati
Cramer Remix: This tech stock was one of the greatest bargains of all time https://www.cnbc.com/2017/08/07/cramer-remix-nvidia-was-one-of-the-greatest-bargains-of-all-time.html Aug 07, 2017 - Jim Cramer reveals the high-flying tech company that was cheaper than many investors had thought.
Dow's 22,000 rally could keep on going Thursday https://www.cnbc.com/2017/08/02/dows-22000-rally-could-keep-on-going-thursday.html Aug 02, 2017 - The Dow jumped across the 22,000 marker for the first time Wednesday, and a wave of earnings news Thursday could keep it going.
GW Pharmaceuticals: Speculative Cannabis https://seekingalpha.com/article/4058761-gw-pharmaceuticals-speculative-cannabis?source=feed_sector_healthcare Mar 29, 2017 - GW Pharmaceuticals is the top way to speculate on cannabis related stocks. Epidiolex could be a true blockbuster drug and provide GW Pharmaceuticals with up to $3 billion per year in sales. GW is stil
Cramer Remix: Where the money leaving retail stocks could be headed http://www.cnbc.com/2017/05/09/cramer-remix-where-the-money-leaving-retail-stocks-could-be-headed.html May 09, 2017 - Jim Cramer pointed to consumer spending on vacations and travel as a possible pull from retail purchases.
Cramer Remix: Yes, Allergan is the anti-bitcoin https://www.cnbc.com/2017/12/07/cramer-remix-yes-allergan-is-the-anti-bitcoin.html Dec 07, 2017 - Jim Cramer called out Allergan for its lack of volatility and said few of its redeeming qualities really matter anymore.
Synergy Pharmaceuticals: An Overlooked $4 Biopharma Stock https://seekingalpha.com/article/4071781-synergy-pharmaceuticals-overlooked-4-biopharma-stock?source=feed_sector_healthcare May 10, 2017 - The shares of Synergy Pharmaceuticals have declined some 40% since its primary drug candidate Trulance was approved by the FDA for the treatment of Chronic Idiopathic Constipation in December.Early sc

Pages: 123456...123

Page 1>

Related Companies

Name Exchange Price Mkt Cap
CELG Celgene Corporation NASDAQ $87.23 $61.35B
SHPG Shire plc NASDAQ $176.25 $46.08B
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $175.8 $44.93B
ZTS Zoetis Inc. NYSE $88.3 $42.55B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $386.665 $41.78B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Allergan plc.